Will Evidence-based Medicine Survive the COVID-19 Pandemic?

Ary Serpa Neto^{1

2}, Carol Hodgson^{1

3}

Affiliations

¹ Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
² Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil; and.
³ Department of Intensive Care, Alfred Health, Melbourne, Victoria, Australia.

Editorial

Ary Serpa Neto et al. Ann Am Thorac Soc. 2020 Sep.

. 2020 Sep;17(9):1060-1061.

doi: 10.1513/AnnalsATS.202006-587ED.

Ary Serpa Neto^{1

2}, Carol Hodgson^{1

3}

¹ Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
² Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil; and.
³ Department of Intensive Care, Alfred Health, Melbourne, Victoria, Australia.

No abstract available

Comment on

Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.
Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW, Ginde AA, Gong MN, Harrell F, Hayden DL, Hough CL, Khan A, Leither LM, Moss M, Oldmixon CF, Park PK, Reineck LA, Ringwood NJ, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Torr DK, Weissman A, Lindsell CJ, Rice TW, Thompson BT, Brown SM, Self WH. Casey JD, et al. Ann Am Thorac Soc. 2020 Sep;17(9):1144-1153. doi: 10.1513/AnnalsATS.202005-478SD. Ann Am Thorac Soc. 2020. PMID: 32492354 Free PMC article. Clinical Trial.

1. Rice TW, Janz DR. In defense of evidence-based medicine for the treatment of COVID-19 acute respiratory distress syndrome. Ann Am Thorac Soc. 2020;17:787–789. - PMC - PubMed
1. Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323:264–268. - PMC - PubMed
1. Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia. Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia [in Chinese] Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:185–188. - PubMed
1. Paton NI, Lee L, Xu Y, Ooi EE, Cheung YB, Archuleta S, et al. Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial Lancet Infect Dis 201111677–683.[Published erratum appears in Lancet Infect Dis 11:655.] - PubMed
1. Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, et al. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis. 2010;4:e785. - PMC - PubMed